Ligand validation:4PL5

PEU: 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4PL5_PEU_A_1004	7%	72%	0.259	0.817	0.46	0.6	-	-	0	0	37%	0.3735
4PL4_PEU_A_1003	16%	40%	0.179	0.883	0.64	1.68	-	2	0	0	23%	0.2289
2WY3_PEU_A_1176	28%	67%	0.114	0.904	0.57	0.71	-	-	0	0	23%	0.2289
4R4K_PEU_C_201	28%	73%	0.127	0.897	0.54	0.51	-	-	0	0	34%	0.3373
3K1E_PEU_A_126	8%	65%	0.264	0.791	0.66	0.68	-	1	8	0	66%	0.6627
2Y7P_PEU_A_1305	6%	31%	0.2	0.772	1.53	1.22	3	2	1	0	28%	0.2771
4OKH_PEU_B_905	6%	77%	0.239	0.819	0.59	0.35	-	-	0	0	16%	15.659999999999998

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.